COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,812 Articles (21,985 medRxiv, 7,827 bioRxiv)

Most recent first Previous |  Page 2767: Articles 27661-27670  | Next

Clinical and Imaging Findings in COVID-19 Patients Complicated by Pulmonary Embolism
Li, T., Kicska, G., Kinahan, P. E., Zhu, C., Oztek, M. A., Wu, W.
10.1101/2020.04.20.20064105 — Posted: 2020-04-24
Evidence-based, cost-effective interventions to suppress the COVID-19 pandemic: a rapid systematic review
Juneau, C.-E., Pueyo, T., Bell, M., Gee, G., Potvin, L.
10.1101/2020.04.20.20054726 — Posted: 2020-04-24
National Consumption of Antimalarial Drugs and COVID-19 Deaths Dynamics : an Ecological Study
Izoulet, M.
10.1101/2020.04.18.20063875 — Posted: 2020-04-24 Discussion: Onsite
Mapping the Immunodominance Landscape of SARS-CoV-2 Spike Protein for the Design of Vaccines against COVID-19
Huang, J.-D., Zhang, B.-z., Hu, Y.-f.
10.1101/2020.04.23.056853 — Posted: 2020-04-24 Discussion: Onsite
STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters
Boudewijns, R., Thibaut, H. J., Kaptein, S. J. F., Li, R., Vergote, V., Seldeslachts, L., De Keyzer, C., Sharma, S., Jansen, S., Van Weyenbergh, J., Ma, J., Martens, E., Bervoets, L., Van Buyten, T., Jacobs, S., Liu, Y., Marti-Carreras, J., Vanmechelen, B., Wawina-Bokalanga, T., Delang, L., Rocha-Pereira, J., Coelmont, L., Chiu, W., Leyssen, P., Heylen, E., Schols, D., Wang, L., Close, L., Matthijnssens, J., Van Ranst, M., Schramm, G., Van Laere, K., Opdenakker, G., Maes, P., Weynand, B., Cawthorne, C., Vande Velde, G., Wang, Z., Neyts, J., Dallmeier, K.
10.1101/2020.04.23.056838 — Posted: 2020-04-24 Discussion: Onsite | Offsite
Rapid, sensitive, full genome sequencing of Severe Acute Respiratory Syndrome Virus Coronavirus 2 (SARS-CoV-2)
Paden, C. R., Tao, Y., Queen, K., Zhang, J., Li, Y., Uehara, A., Tong, S.
10.1101/2020.04.22.055897 — Posted: 2020-04-24
Impact of control strategies on COVID-19 pandemic and the SIR model based forecasting in Bangladesh.
Rahman, M. M., Ahmed, A., Hossain, K. M., Haque, T., Hossain, M. A.
10.1101/2020.04.19.20071415 — Posted: 2020-04-23
Optimal control of the COVID-19 pandemic with non-pharmaceutical interventions
Perkins, A., Espana, G.
10.1101/2020.04.22.20076018 — Posted: 2020-04-23
A cell phone data driven time use analysis of the COVID-19 epidemic
Fenichel, E. P., Berry, K., Bayham, J., Gonsalves, G.
10.1101/2020.04.20.20073098 — Posted: 2020-04-23
Characteristics of scientific articles on COVID-19 published during the initial three months of the pandemic: a meta-epidemiological study
Di Girolamo, N., Meursinge Reynders, R.
10.1101/2020.04.20.20073130 — Posted: 2020-04-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).